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Abstract
Background: Adolescents with severe restrictive eating disorders often require enteral feeding to provide lifesaving
treatment.
Nasogastric feeding (NG) is a method of enteral nutrition often used in inpatient settings to treat medical instability,
to supplement poor oral intake or to increase nutritional intake. This systematic review sets out to describe current
practice of NG in young people with eating disorders.
Methods: A systematic review following PRISMA guidelines was conducted by searching AMED, EMBASE and MEDL
INE databases from 2000 to 2020. Inclusion terms were: enteral feeding by nasogastric tube, under 18 years, eating
disorders, and primary research. Exclusion terms: psychiatric disorders other than eating disorders; non-primary
research; no outcomes specific to NG feeding and participants over 18 years. Titles and abstracts were screened by
all authors before reviewing full length articles. Quality assessment, including risk of bias, was conducted by all
authors.
Results: Twenty-nine studies met the full criteria. 86% of studies were deemed high or medium risk of bias due to
the type of study: 34.4% retrospective cohort and 10.3% RCT; 17.2% were qualitative. Studies identified 1) a wide
range of refeeding regimes depending on country, settings, and the reason for initiation; 2) standard practice is to
introduce Nasogastric feeds (NG) if medically unstable or oral intake alone is inadequate; 3) NG may enable greater
initial weight gain due to increased caloric intake; 4) there are 3 main types of feeding regime: continuous,
nocturnal and bolus; 5) complications included nasal irritation, epistaxis, electrolyte disturbance, distress and tube
removal; 6) where NG is routinely implemented to increase total calorie intake, length of stay in hospital may be
reduced; however where NG is implemented in correlation to severity of symptoms, it may be increased; 7) both
medical and psychiatric wards most commonly report using NG in addition to oral intake.
Conclusions: NG feeding is a safe and efficacious method of increasing total calorie intake by either supplementing
oral intake or continuously. There are currently no direct comparisons between continuous, nocturnal or bolus regimes,
which may be used to direct future treatment for YP with ED.
Keywords: Nasogastric, Enteral feeding, Restrictive, Eating disorders, Young people, Adolescents, Inpatient, Anorexia
nervosa
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: kristen.hindley@student.manchester.ac.uk
1University of Manchester, Manchester, UK
Full list of author information is available at the end of the article
Hindley et al. Journal of Eating Disorders            (2021) 9:90 
https://doi.org/10.1186/s40337-021-00445-1
Plain english summary
Young people with eating disorders often restrict food intake to a degree which is detrimental to their physical health.
Depending on the severity of psychiatric and medical symptoms, patients may be admitted to a mental health or
medical ward. In the circumstances that their BMI is detrimentally low, a nasogastric (NG) tube may be placed from
nose to stomach to pass nutrition. This systematic review sets out to review the current reported evidence of NG in
young people. Results have shown that NG feeding is used commonly in the hospital setting to treat medical
instability as a result of severe malnourishment, and in the specialist eating disorders (ED) unit due to failure to meet
oral intake. NG feeding may be administered through different methods such as continuously, multiple single meals
(bolus), or overnight to supplement day-time oral intake. Routine NG feeding may allow greater initial caloric intake,
which does not increase risk of medical complications, and may actually increase initial weight gain thus reducing time
in hospital. Differences may be due to variable expertise of staff. Side effects are minimal but may include nasal
bleeding or irritation, and imbalances in blood electrolytes which can be reduced by providing supplementation.
Keywords: Nasogastric, Enteral feeding, Restrictive, Eating disorders, Young people, Adolescents, Inpatient, Anorexia
nervosa
Background
There are currently over 700,000 individuals in the UK
with an eating disorder (ED) [1]. EDs usually manifest
prior to adulthood, with an average age of onset of ap-
proximately 15 years, although this is decreasing; with
new research from NICE demonstrating that incidence
in children aged 12 and under had increased between
2005 and 2015 in the UK [2, 3]. Patients with restrictive
eating disorders, including anorexia nervosa (AN), bu-
limia nervosa (BN) and eating disorder not otherwise
specified (EDNOS), are predominantly female (91%) and
Caucasian (92%), with incidence being approximately
0.014 for females [3]. Compared to other mental ill-
nesses, EDs have a high mortality rate with young people
(YP) with anorexia nervosa (AN) on average 6–10 times
more likely to die than the general population [4, 5].
Death is often caused by cardiac abnormalities associ-
ated with extremely low bodyweight [6]. For this reason,
acute medical intervention is often warranted in order to
reduce mortality. Nasogastric (NG) feeding use in YP
with ED may be used as a lifesaving treatment when pa-
tients are physically unwell [7, 8]. However, refeeding is
also a critical component to recovery and NG feeding
will often be utilised if a young person has been unable
to manage oral intake in order to prevent signs of phys-
ical unwellness [9, 10].
NG feeding involves a fine bore tube passed via the
nasal passage into the stomach in order to administer nu-
trition. There is a low risk of complications associated
with NG feeding if staff receive adequate training and pro-
tocols are enforced to ensure that the tube has been
passed correctly [11]. Different methods of NG may be
utilised safely, with NG feeds often given as large bolus,
continuously through a pump or overnight in order to
supplement daytime oral intake [12, 13]. Recent guidance
from the British Dietetic Association [14] for NG feeding
under restraint advised 1–2 bolus feeds per day even in
those with high risk of refeeding syndrome (RS); it also
concluded further research into this area was required.
The National Institute for Clinical Excellence has pro-
duced guidance for providing nutrition recommending a
graded approach [15]. Neither of these guidelines are spe-
cific for children and adolescents.
Most EDs will be treated in an outpatient setting with
hospitalisation generally reserved for those with severe
malnutrition resulting in physical symptoms such as
bradycardia, hypotension or dehydration as set out in
the MARSIPAN guidance [16]. Research on NG feeding
in YP has tended to focus on the acute refeeding phase
in paediatric or psychiatric wards to reduce the risk of
RS [17]. RS can manifest as hypophosphatemia (HP),
hypomagnesemia, hypokalemia and other electrolyte im-
balances that result in cardiac arrhythmias, seizures and
in some cases sudden death [18]. During the acute
refeeding phase the need for weight restoration must be
balanced against the risk of developing RS. Most patients
(96%) however present less severely with serum hypo-
phosphataemia and no clinical signs [19]. Although there
is a significant body of research into this, the role of NG
feeding remains ill-defined [17].
Moreover, for clinicians, there is currently conflicting
guidance on how to manage NG feeding in YP with ED,
in particular how and when to transition between oral
and NG feeding [20, 21]. This has resulted in a variety of
NG feeding practices across different settings, with many
medical wards tending to provide continuous NG feeds
and cease oral intake in order to medically stabilise the
patient [20, 22–26]; in contrast mental health wards or
specialized eating disorder programs housed on medical
wards may be more likely to use syringe bolus feeds to
provide food when meals are refused, encouraging oral
intake and aiding normalisation of eating [9, 18, 27–31].
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In a recent systematic review [32] 9/10 studies in hospi-
talised ED patients are given continuous or overnight
supplemental NG feeding.
Previous reviews [32, 33] have examined use of NG
feeding in ED, including the safety and efficacy of NG
feeding as well as short-term and long-term outcomes.
However, this will be the first systematic review on the
use of NG feeding specifically in YP with ED. Due to the
anticipated paucity of studies in this area any research
where a meaningful conclusion or result can be drawn re-
garding NG use in YP with ED will be included. This re-
view aims to assess strategies for the use, tolerance and
effectiveness of NG feeding in YP with restrictive ED.
Methods
A comprehensive database search of AMED, EMBASE,
APA Psychinfo and MEDLINE was performed with no
language restriction from January 2000 to July 2020.
Search strategies combined keywords with controlled vo-
cabulary terms (MeSH, Thesaurus); both quantitative
and qualitative research were included. The search cri-
teria was peer reviewed by a researcher from the Univer-
sity of York’s Child and Adolescent Mental Health
Intervention Centre. References were exported and du-
plicates were removed using the title and abstract.
Screening for eligible studies
The full search is available in Appendix 1. The inclusion
criteria were: NG feeding, participants under 18 years,
eating disorders, published since 2000 and primary re-
search. The outcomes of interest were: Opinions of YP
and staff using NG, amount of YP requiring NG, any in-
terventions that impacted on NG feeding, complications
of NG feeding, interventions to mitigate the complica-
tions, the setting (medical ward, psychiatric ward or out-
patient), the NG method and whether this changed
when restraint was required. The exclusion criteria in-
cluded: No ability to discern results specific to NG feed-
ing, mental disorders other than eating disorders being
the focus, where the majority of participants are over 18
years or it is impossible to separate results for adults
from YP, reviews or other non-primary research and re-
search published before 2000.
Studies published in languages other than English were
translated prior to being reviewed. The PRISMA flow-
chart was used (Fig. 1). Abstracts identified from the ini-
tial search were screened in a secondary review process,
and full text papers were obtained of those meeting the
inclusion criteria or where there was uncertainty. One
article published prior to 2000 was included in the full
text review due to it requiring translation prior to asses-
sing it against the criteria. Key studies were manually
reviewed for additional research, but none were identi-
fied that were not already included, 1 eligible study was
identified through peer review. There was no disagree-
ment between CF and KH who assessed which studies
were included.
Figure 1 displaying PRISMA flowchart of methodology
utilised to search databases for this systematic review of
enteral feeding in young people with restrictive eating
disorders.
Assessing study quality
There is no validated method to assess the retrospect-
ive and qualitative nature of studies included there-
fore we could not conduct a formal quality
assessment or statistical method to evaluate the re-
sults. The risk of bias was estimated into high,
medium or low using an adapted version of the
Agency for Healthcare Research and Quality risk of
bias tool as described in Myers [34] which included
an assessment of the bias in the selection of partici-
pants, sample size, tools used to assess change and
whether the study involved blinding. The studies were
analysed for risk of bias independently by CF, KH
and JM. The risk of bias was deemed to be medium
or high (see Additional file 1: Appendix 2) for the
majority of the studies included due to the nature of
their design, being case series or retrospective cohort
studies. Table 1 includes a summary of included stud-
ies. Results interpreted from studies with a high risk
of bias were removed accordingly, leaving only high
quality results and conclusions.
Fig. 1 PRISMA Flowchart
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Results
Prevalence and epidemiology
YP with ED requiring NG were often medically unstable
on admission [9, 18, 20, 22, 23, 25, 39] and NG feeding
was implemented as standard practice [22, 23, 26, 39]. NG
was also implemented due to acute refusal of food or in-
ability to meet oral intake, without significant medical in-
stability, in five studies [9, 10, 18, 31, 43]. In 13 studies (3
high risk of bias [28, 35, 47]) in which NG was not imple-
mented as standard protocol for all patients, the percent-
age of ED YP administered NG feeding in all contexts
(due to medical instability or inadequate oral diet) varied
between 6 and 66% [9, 18, 29, 31, 36, 37, 41–44].
Two studies [37, 43], found NG feeding was more
likely to be required in: patients of a lower age at admis-
sion (14.3 years compared to 15.3 yrs. old, P < 0.05 [37]
and 20% in early onset AN compared to 0% in adult on-
set AN P < 0.05 [43]). Clausen [46] described NG as the
most frequently used involuntary measure in psychiatric
practice and is most commonly used in 15–17 year olds.
Studies included both male and female patients, how-
ever, out of 25 patient focused studies, most had a fe-
male majority and 6 studies [20, 26, 37, 39, 43, 44] were
conducted on female only cohorts. 2 studies [21, 47] ex-
amined male only cohorts but both were high risk of
bias. 1 study [39] included only Caucasian participants
however the majority of studies were conducted in afflu-
ent, Caucasian majority countries; 31% of the studies in-
cluded were set in Australia, 14% in the USA, 10% in
Canada. There were no studies from Asia, South Amer-
ica or Africa. In Australian based studies, NG was given
due to refusal of oral intake in 2 studies [9, 10] as well
as to treat medical instability [26]. Globally studies from
North America [18, 21, 39, 41] and Turkey [36] focused
on medical instability in YP with ED. In the UK, three
studies described NG use during medical instability after
oral intake was refused [27, 28, 40] and one where oral
intake was inadequate [31].
Reported weight gain
Four studies reported weight gain primarily in the con-
text of ED YP with medical instability [24–26, 44]. 2 of
these studies [24, 26] for the first 24–72 h started with
continuous NG feeding, using higher than standard cal-
orie protocols, 2400–3000 kcal per day prevented any
initial drop in weight. Between admission and discharge,
Parker et al [24] reported a mean overall weight gain of
7.4kgs, Kezelman 2018 [26] reported a mean overall in-
crease of 3.04 kg/m2 BMI; Madden et al [25] reported a
mean weight gain of 2.79 kgs during medical instability
using continuous NG feeding at 2400 kcals per day.
Skrik Liever et al [44] reported 27% required NG feeding
and linked this to a faster weight gain but gave no infor-
mation related to NG feeding protocols.
Three studies reported weight gain in the context of
inadequate oral intake [9, 18, 39]. Maginot et al., 2017
[18] and Whitelaw et al., 2010 [9] reported NG bolus
feeding in 13.8 and 15% in order to supplement oral diet
with a mean weight gain of 3.1kgs and 2.6kgs respect-
ively but did not report if this was specific to NG feed-
ing. Robb et al [39] compared nocturnal NG feeding to
supplement oral diet (maximum 3255 kcals /d) with oral
intake (max 2508 kcals/d) reporting nocturnal NG feed-
ing weight gain of 5.4kgs versus 2.4kgs in the oral diet
only group.
One study reported on weight gain where NG is rou-
tinely started on all ED YP regardless of context [23].
Agostino et al [23] compared a higher calorie (1500-
1800 kcal/d) continuous NG fed cohort to lower calorie
oral bolus cohort (1000-1200 kcal/d, divided 6 times per
day), results showed mean weight gain was greater in
the continuous NG fed group (1.22 kgs per week) than
the oral bolus fed group (0.08 kgs per week) over the
first 2 weeks.
Patient and staff experience of nasogastric feeding
Five studies used qualitative methods to analyse patient,
parent and professional opinions on NG feeding [10, 20,
40, 45, 48]. A survey of dietitians found 82% considered
NG feeding a necessary procedure if oral diet is inad-
equate [10]. Psychiatric nursing assistant’s views centred
around: NG being an unpleasant practice, becoming sen-
sitized or desensitized, and the importance of developing
coping mechanisms to manage the distress.
An Australian study [45] (conducted in a paediatric
unit) found YP viewed being NG fed as: an unpleasant
experience, a necessary intervention, a psychological sig-
nifier of illness, and an emphasis in an underlying strug-
gle for control. Some described NG feeds as easier than
eating as it “disguised” the amount due to not swallow-
ing; others felt it was a form of punishment for not gain-
ing enough weight. Conversely the YP in Paccagnella
and colleagues [20] research stated NG was helpful, par-
ticularly initially when an oral diet was challenging to
manage.
Feeding regime and calorie intake
A variety of different feeding regimes were identified in
this review which are summarised in Table 2. Refeeding
protocols daily calorie intake varied greatly between
studies particularly as many studies were evaluating the
outcome of higher calorie refeeding protocols [9, 18, 22,
24, 31]. Most studies tailored the calorie requirements to
the individual patient, accounting for initial weight for
height percentage and signs of medical instability. The
majority commenced on daily intake of less than 2000
kcal and increased periodically.
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Table 2 Nasogastric Feeding Protocol and Complications Identified in Studies Included in this Systematic Review
Study Risk of
Bias








Oral intake supplemented with
bolus NG feeding if oral RDI not
met
Minimum of 1900kcals on day 1 and
increased by 300 kcal per day
38% developed HP. HP was







High energy supplements and NG
feeds were commonly used to meet
RDI.
The initial calorie intake








Bolus NG feeds supplemental to
oral intake if RDI not met
Average of 1185 kcal average which
increased to an average of 1781
kcals (range 1500–3000 kcals)
Hypomagnaemia and HP reported,





Medium Unknown Continuous NG feeding until
medically stable
15.9–19.7 kcal/kg/day; increased to
30 kcal/kg/day after 24 h.
No patient developed nausea,
vomiting, or worsened abdominal
symptoms; 2 developed lower limb
oedema despite slow infusion.
Silber et al,
2004 [21]
High MH Ward Routine nocturnal NG feeding to
supplement daily oral intake vs oral
refeeding only (control)
Nocturnal NG feeding regime
patients were prescribed calories
individually (max 4350 kcal) and








Continuous NG feeding until
medically stable; followed by oral
intake with supplemental nocturnal
NG feeding until biomarkers
stabilised.
NG feeding continuously for 1–2
days. Weight gain aim for 1 kg per
week. Weaning to oral diet occurred
as soon as medically stable –
average 14 days on NG with feed of







Routine continuous NG feeding at a
higher calorie intake compared to
lower calorie standard oral intake.
Starting range for NG cohort 1200-
2000 kcal increased by 200 kcal/day
vs. oral diet of 800-1200 kcal in-
creased by 150 kcal/day. NG fed for
7 days then weaned over 3 days
with kcal via NG reducing as meals
replaced
Oral cohort 51% lost weight initially
compared to 6% in the NG high
kcal cohort. 2 cases of




Medium MH Ward Continuous NG feeding or
combination of oral intake with
supplemental overnight NG feeding,
or oral intake alone.
Start feed 2400 kcal increasing to




hypokalaemia (2%), HP (1%). No






Continuous NG feeding until
medically stable; followed by oral
intake with supplemental nocturnal
NG feeding until biomarkers
stabilised. Average %IBW at
initiation was 78
2400-3000 kcal to meet weekly
target of weight gain of 1 kg/week.
In the first week average weight
gain was 2.79 kg.






Continuous NG until medically
stable followed by oral intake
supplemented by nocturnal NG
feeding
2400 kcal/day for 24 h or until
medically stable, changed to oral
diet starting ~ 1800 kcal increasing
to a maximum of 3800 kcal with
nocturnal NG top up feeds stopped




Medium MH Ward Results from questionnaire showed
non-specialist psychiatric units gave
73% NG as syringe bolus, 27% as
enteral pump. Specialist ED units
gave 85% as syringe bolus, 15% as
enteral pump.
Volume of bolus feed ranged from
330 to 1000ml average 564ml per
feed. Bolus feed time ranged
between 10 and 40 min average
being 20 min. If delivered by pump






Bolus NG feeding if medically
unstable and oral intake not met
NG feeds were higher in calories






Medium MH Ward Bolus NG feeding if patient failed to
gain 1 kg/week or acute refusal of
meals
Not discussed Nausea, odynophagia, self-harm,
epistaxis, anxiety, sadness, 38.4%
patients experienced mild HP
Falcoski High MH Ward Oral calories supplemented with Starting feed 1200 kcal, increased by Distress described during the
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No study discussed in detail the strategy used to tran-
sition from NG feeds back to an oral diet. Those studies
where NG was used for medical stabilisation often de-
scribed a short period of NG before a quick transition
back to an oral diet [22, 23, 36]. In studies where con-
tinuous NG was provided, YP were sometimes not given
the option of an oral diet so that their calorie intake
could be closely monitored [22–24, 31]. These studies
discussed ceasing NG feeds after the risk of RS had re-
duced; most gave a time frame between 2 and 14 days
[24, 44]. Studies using bolus feeds stated that oral intake
was encouraged and it was only when this was not fully
achieved that supplementary NG was used [39]. This ap-
peared to be either after each meal, at set times during
the day or once in the evening [27]. For nocturnal feeds,
oral diet was encouraged during the day. In most studies
the NG feed supplemented any deficit in oral intake but
occasionally also provided additional calories above
those prescribed in the oral meal plan [22, 25, 39].
Length of time receiving NG feeding
There was a wide variety in length of time receiving
NG for medical instability. Agostino and colleagues
[23] delivered nutrition on a medical ward solely via
NG for 14 days before commencing oral diet in
addition to NG feeding. The average length of time
on NG feeding in this study was 20.7 days; NG was
terminated as YP accepted more than 50% oral caloric
quota compared to theoretical reported quota. Mad-
den et al [22] RCT determined the duration of NG
feeding was a minimum of 14 days, using biochemical
markers of medical instability in a hospital setting.
Conversely, Akgul and colleagues [36] described a
much shorter average time, 2.5 days, that YP required
NG before transitioning to an oral diet. Conversely,
in MH wards, if NG has to be given under restraint,
it may be required for a significant duration; in one
study [46] the average was 170 days. Neiderman et al
[40] qualitative study describes patients time receiving
NG varying from 1 to 476 days (methods not
explained).
Two studies examined therapeutic interventions to re-
duce the need for NG or length of time on it in medic-
ally stable YP [29, 41]. Couturier and Mahmood [29]
highlighted that meal support therapy reduced the re-
quirement for NG feeding from 66.7 to 11.1%, criteria
for NG feeding was the same in both groups throughout
and oral intake was encouraged. Gusella and colleagues
[41] compared parent led therapy (PLT) to non-specific
therapy (psychologist led talking therapy). PLT was
based on FBT and included parents reducing child exer-
cise and increasing oral intake. Results demonstrated
that YP receiving PLT had a significantly reduced re-
quirement for NG (P < 0.05).
Table 2 Nasogastric Feeding Protocol and Complications Identified in Studies Included in this Systematic Review (Continued)
Study Risk of
Bias





bolus NG feeds, single bolus of high
calorie NG feeding, and 3 smaller
single boluses.
200 kcal per day to 2000 kcal. 1 NG
feed per day under restraint. Also
described 1 bolus feed of 2000 kcal







Supplemental bolus NG feeding if
patients failed to meet 80% RDI. At
initiation %IBW was < 78%





High MH Ward Not discussed Initiated at 750 kcal per day and
increased by 220 kcal per day
HP described in 2 cases (unable to






Not discussed, the majority of
young people were under 80%
%IBW
Started on an average of 975 kcal.
Average duration of NG was 2.5
days
HP described in 2 cases (not stated





Nocturnal NG feeding to
supplement daily oral intake during
medical instability
Starting NG feed at 600 kcal. Ratio
oral kcal to NG was approximately 2:
1. NG feed via pump at 40 cc per
hour for 4 h then 60 cc per hour for
4 h. Increases to 1200 kcal NG feed
over 3 nights. Weaned when the
young person is 95%IBW.
Epistaxis (11.5%), anxiety (3.8%)
treated with Lorazepam, removal of







Not discussed Not discussed Removal of tube (55%).
Key: BMI Body Mass Index, NG Nasogastric, MH Mental health, RDI Recommended daily intake, HP Hypophosphataemia, RS Refeeding syndrome, %IBW Percentage
ideal bodyweight
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Complications associated with NG feeding
Complications associated with NG feeding found in this
review are summarised in Table 2, with the most fre-
quently described being nasal irritation or epistaxis, anx-
iety related to the procedure and electrolyte disturbance
(which occurred with both oral and NG refeeding).
Overall, this review found 5 studies [9, 18, 23, 24, 29] re-
ported some incidence of electrolyte disturbance, 2 stud-
ies [29, 39] described epistaxis and 1 study [39]
described behavioural problems associated with the pro-
cedure. A number of YP in MH wards required restraint
to NG feed with one study reporting this was required
for 66% of YP [24]. NG under restraint was described as
causing distress and risk of injury to both staff and YP
[48]. No study reported a YP developed RS. Nehring and
colleagues [37] concluded that NG feeding had no im-
pact on growth, recovery or development of psychiatric
co-morbidities.
Kezelman and colleagues (Australia) 2018 [26] assessed
the impact on anxiety, depression and ED symptoms
when using NG in adjunct to oral intake as part of a rapid
refeeding regime. Changes in these symptoms were not at-
tributed to the rate of weight restoration suggesting a
rapid refeeding schedule would not exacerbate psychiatric
symptoms.
Length of stay associated with NG feeding
Length of stay was reported in studies from medical and
MH ward settings, however, the specific package of treat-
ment YP received in each study was different depending
on the country of origin. For example, in Australian stud-
ies medical wards tended to include high levels of psychi-
atric treatment alongside medical treatment [26].
Agostino and colleagues [23] demonstrated that YP on
medical wards having NG feeds had a mean LOS of 33.8
days compared to those in the same setting having an oral
diet who had a mean of 50.9 days, however, the oral diet
was lower in calories therefore taking longer for weight re-
covery and medical stabilisation. Conversely any hospital
admission was significantly longer (P < 0.0001) for a YP
requiring NG feeding compared to those managing an
oral diet in a German retrospective cohort study [37].
However, this study does not discuss the reasons NG was
implemented. Maginot et al. study [18] in a medical ward
(where NG was implemented due to insufficient oral in-
take) discussed NG feeding in the context of YP with
more severe medical problems, (such as intractable vomit-
ing and superior mesenteric artery syndrome) which
therefore took longer to transition to oral diet, resulting in
a longer admission.
Strik Lievers and colleagues [44] concluded that,
amongst others, requirement for NG feeding when NG
was implemented due to medical instability was a factor
affecting LOS on a psychiatric ward. In this study the
mean LOS was significantly increased: 117 days for YP
managing oral intake compared to 180 days for those re-
quiring NG. They concluded that the requirement for
NG was an indication of severity and resistance to oral
feeding [44].
Discussion
It is evident that there is a wide variety of practices re-
garding implementation and regime of NG feeding in YP
with eating disorders globally [9]. Given that the proced-
ure can be painful [48] for YP and cause complications
[29, 39], there is an urgent need for research exploring
this wide variation in use of NG feeding to enable future
direction and best practice guidance clinicians. A review
conducted by Rizzo and colleagues [49] (2019), which
focused on NG for acute refeeding, also found a wide
variety of practices.
From this systematic review 3 methods of NG feeding
in YP with ED were found: continuous [23, 25], noctur-
nal [26, 29], and bolus meal replacement [9]. It is not
possible from this review to discern the advantages and
disadvantages of each method as no study made a direct
comparison. When NG feeding is used under restraint
bolus feeds are preferred due to concerns around the
tube being removed by the YP once restraint had ceased
[45]. The main disadvantage to bolus feeding, in medic-
ally stable YP, is that the NG tube requires reinsertion
each time a feed is required, however, it provides a tan-
gible motivation to eat the full meal plan provided
which, in practice, should always be encouraged over
NG feeding in order to promote patient wellbeing. Fur-
ther research is required to assess which method is the
safest, most efficacious and best aids transition back to a
fully oral diet.
Medical wards used continuous feeding more fre-
quently than MH wards, however this tended to be for a
short period of time while the YP was medically un-
stable, after this they would be transitioned to an oral
diet [22, 23, 25, 26]. It is probable that medical wards
primarily manage YP for short periods to stabilise acute
physical health deterioration, while MH wards admit
relatively medically stable YP and seek primarily to treat
psychological ED symptoms that are preventing an ad-
equate oral diet. This difference could account for the
divergent outcomes from studies on the impact NG has
on the LOS between medical and psychiatric settings
[23, 44].
Similar to the review conducted by Hale and Logomar-
sino [33] who found RS to be a rare complication, it is
reassuring to find that no study in this review reported
YP developing RS despite some studies starting on high
calorie NG feeding plans [9, 18, 24, 42]. Although com-
plications such as electrolyte abnormalities did occur
there was no evidence that this was attributable to the
Hindley et al. Journal of Eating Disorders            (2021) 9:90 Page 10 of 13
NG feeding compared to oral diet [9, 18, 23, 24]. The re-
sults of this review support the conclusions from Rizzo
and colleagues [49] (2019) that NG feeds can be safely
administered and have the advantage of shortening LOS
when used to increase total caloric intake. However, fur-
ther research is required to assess the optimum NG
feeding regime for YP at different levels of RS risk. In
two studies intensive meal support and concurrent ther-
apy reduced the number of NG episodes (in medically
stable YP) before managing a full oral diet [29, 41]. This
could have the advantage of reducing LOS in medically
stable YP.
There are a number of limitations to the conclusions
that can be drawn from this review. The majority of
studies included were retrospective and based around
case note reviews which are subjective and therefore
likely to be biased. A retrospective design also creates se-
lection bias as those lost to follow up are not considered.
Bias can also occur due to the different treatment groups
being recorded at different times thus confounding vari-
ables may include different staff working at the setting
and therefore different methods of treating YP. Only
52% of studies were conducted prospectively. Three
studies were qualitative interview studies, examining pa-
tient or staff feelings towards NG feeding in practice
which increases the risk of confirmation bias. The ma-
jority also had a relatively small sample size, again
introducing the possibility of bias and reducing
generalizability. 58% of the studies included only exam-
ined the effect of NG feeding as a secondary outcome of
their study. It is not possible from these studies to make
any comparison between NG feeding and oral intake
due to the confounding effect that for the vast majority
of studies only high risk, medically unstable YP were
considered for NG feeding. Pragmatic, prospective stud-
ies that control for this confounder are required for any
such comparison to be made.
Conclusions
This review describes the large differences in the use
of NG for YP with ED in medical and psychiatric
wards in a number of countries globally. NG feeding
is an important aspect of treatment for YP with ED
who are medically unstable and/or unable to manage
an adequate oral diet. Although there are some RCT’s
examining aspects of NG use in YP with ED the ma-
jority of studies were retrospective cohorts or case
series. There is a need for more high quality data in
when to initiate NG, comparing different methods of
delivering NG feeds and transitioning from NG to
oral diet in YP with restrictive ED to enable future
direction for clinicians.
Appendix 1
1. Naso-gastric or nasogastric or *enteric or *enteral
or tube
2. (Anorexia or bulimia or eat* or feed*) NOT bowel
NOT surgery NOT intestin*
3. (child* or paed* or adolescen* or teen* or young)
NOT baby NOT toddler NOT infant NOT animal
NOT maternal NOT parental NOT learning disabl*
NOT learning disabil*
4. 1 AND 2 AND 3
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